Streetbeat News

Assets

SLE

Super League Enterprises (NASDAQ:SLE) has been granted a new patent by the United States Patent and Trademark Office (USPTO) for AI-driven optimization of live streaming content. The patent pertains to the production and intelligent prioritization of simultaneous perspectives within virtual environments, particularly video games. The company's creative studio has been a significant contributor to its business, producing content for brands like MTV and Samsung.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:19 pm

CORT

Corcept Therapeutics Incorporated (NASDAQ:CORT) has appointed Monica Tellado as President, Emerging Markets. Tellado, who previously served as CFO at Heartflow and held various leadership roles at Gilead Sciences, will report to Corcept's CEO and join the company's Executive Team. She will serve as the global commercial lead for therapeutics in metabolism and neurology and oversee pipeline and portfolio planning activities across the company's other therapeutic areas.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:17 pm

SPY

The ADP Nonfarm Employment Change for October was reported at 113K, which is lower than the estimated 150K and the prior figure of 89K.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:15 pm

RILY

SNCR

TSXV:LMN

Synchronoss Technologies (SNCR) has announced the sale of its Messaging and NetworkX businesses to Lumine Group (TSXV:LMN) for up to $41.8 million. This move is part of an ongoing strategic review process aimed at maximizing shareholder value. The sale will allow Synchronoss to focus on its cloud business and improve its capital structure. The company expects gross margins of over 70% and adjusted EBITDA margins of over 25% by the end of fiscal year 2024. B. Riley Financial (RILY), Synchronoss' largest shareholder, supports the transaction.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:02 pm

GLD

SPY

UUP

On October 31st, U.S. stock markets closed positively with all S&P 500 sectors rising. The Dow Jones, S&P 500, and Nasdaq Composite all saw gains. However, Wall Street’s main indices marked their third straight monthly decline. Asian markets saw mixed results, with Japan’s Nikkei 225 and Australia’s S&P/ASX 200 rising, while China’s Shanghai Composite and Hong Kong’s Hang Seng Index saw minor changes. European markets were also mixed. Commodities saw crude oil rise, while natural gas and gold declined. U.S. futures were down, and the U.S. Dollar Index gained.

Portfolio Pulse from Akanksha Bakshi

November 01, 2023 | 11:39 am

NMRA

Neumora Therapeutics reported Q3 losses of $(1.14) per share, a 7.55% decrease YoY. The company has $519.5M in cash, cash equivalents, and marketable securities, expected to provide a cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:23 am

CCCC

C4 Therapeutics has announced that its cash, cash equivalents, and marketable securities total $246.4M, which is expected to provide financial stability into the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:20 am

AMRN

Amarin is making progress in reducing its operating expenses and managing its cash position. The company is on track to deliver $40M of annual savings based on the reduction in force announced in July.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:17 am

BIP

CYXTQ

DLR

Brookfield is set to acquire substantially all of Cyxtera's assets for $775M. The deal includes a comprehensive agreement with Digital Realty Trust and Digital Core REIT for Brookfield to acquire the real estate supporting several of Cyxtera's U.S. data centers.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:17 am

EYPT

EyePoint Pharmaceuticals has reported Q3 cash, cash equivalents, and investments of $136M, which is expected to provide a cash runway into 2025.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:16 am